James is a director at Brunswick Group, advising Fortune 500 and FTSE 100 companies and global foundations. For more than two decades, he was a journalist in the UK, Australia, the US and Czech Republic. As a health reporter and editor at Bloomberg News, he focused on the Covid vaccine rollout and the evolution of the coronavirus, contributing to Businessweek magazine. Previously, he covered energy and the environment from Sydney. James has interviewed scientists, CEOs, billionaires, Nobel Prize winners, patients, sports stars and investors, writing about biotech, climate change, the economy and more.